Articles written by Franca Quarneti - Benzinga

FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays

FDA approves Phase 2 cannabis trial for veterans with PTSD, funded by Michigan marijuana taxes. Study to assess smoked cannabis efficacy.

Kadokawa CEO Confirms Sony's Buyout Interest: 'No Decision Has Been Made'

Sony has confirmed it is in early talks to acquire Kadokawa, which owns Elden Ring's FromSoftware and other major gaming studios.

Play PS5 Games Without A Console: PlayStation Portal Adds Cloud Streaming

PlayStation Portal now supports cloud streaming for PS Plus Premium members. Stream over 120 PS5 games in beta.

Starfield Reaches 15 Million Players With Updates, New Content

Starfield reaches 15 million players, with Bethesda introducing a new update featuring a vehicle, quest, and gameplay improvements.

EXCLUSIVE: Wall Street Meets Main Street — Fintech Experts Weigh In On Retail's Rise

Retail trading now drives nearly half of U.S. equity volume. Fintech leaders at Benzinga Fintech Deal Day discuss innovation, risks and more

Sony Eyes Mobile Growth With Fresh Leadership Appointments

Sony appoints Olivier Courtemanche and Justin Kubiak to lead its mobile division as the company expands its focus on mobile gaming.

Xbox Game Pass Brings Big Titles In Late November, Including Stalker, Microsoft Flight Simulator 2024

Xbox Game Pass adds big titles like Stalker 2 and Microsoft Flight Simulator 2024 in November, while several fan favorites exit.

Sony In Talks To Acquire Elden Ring Publisher Kadokawa: Report

Sony is in talks to acquire Kadokawa, the company behind Elden Ring and top anime IPs, in a potential $2.7 billion deal.

The Game Awards 2024 Nominees Are Here: DLC And Remakes Make The List

These are The Game Awards 2023 nominees, featuring DLC, remakes, and live-service updates for the first time. See who made the cut this year!

6 Games To Leave Xbox Game Pass By End Of Month, Including Soccer Story And Rollerdrome

Xbox Game Pass is losing six games, including Rollerdrome and Conan Exiles. Explore the full list and what's replacing them this month.

Roblox Enhances Parental Controls: 'There's Always More To Be Done'

Roblox introduces parental controls, messaging limits, and game restrictions to enhance safety for its young users amid ongoing scrutiny.

Trump-Appointed Doug Collins To Lead VA: What's Next For Cannabis and Psychedelics In Veterans' Healthcare?

Doug Collins' nomination to lead the VA raises questions about how he might handle medical cannabis and psychedelics policies.

A New StarCraft FPS? Blizzard's Latest Job Posting Hints At Huge Project

Blizzard's latest job posting hints at an open-world StarCraft FPS. Could this be the long-awaited game fans have been hoping for?

Sophie Turner Set To Star As Lara Croft In Amazon's Tomb Raider TV Series: Report

Sophie Turner is reportedly in talks to play Lara Croft in Amazon's live-action Tomb Raider TV series. Here's what we know about the project.

Phil Spencer Responds To 'This Is An Xbox' Criticism: 'We're In The Middle Of A Transition'

Microsoft's ‘This Is An Xbox' campaign has fans divided, with Xbox boss Phil Spencer defending the brand's shift beyond consoles.

1.8 Million Instances Of Hate Content On Steam — Is Valve Ignoring Extremism?: Report

A new ADL report claims Steam hosts over 1.8 million instances of hate content. Valve's response is under scrutiny — will it make changes?

Embracer's Earnings Struggle As Game Delays, Restructuring Weigh On Results

Embracer Group's Q2 financials show a 21% drop in sales and job cuts as the company contends with game delays.

Snapchat Puts Family On The Map With New Real-Time Locator

Snapchat introduces location sharing for families, but the new feature arrives amid privacy concerns and a lawsuit.

GTA 5 Joins November's PlayStation Plus Lineup With Other Fan-Favorites

PlayStation Plus announces an exciting November 2024 lineup, featuring GTA V, Dying Light 2, and timeless classics.

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory hurdles.